Sponsorship Letter for Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.'s Issuance of Convertible Bonds to Unspecified Objects and Listing on the Main Board

Sponsorship Letter

Sponsorship Letter for Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.'s Issuance of Convertible Bonds to Unspecified Objects and Listing on the Main Board

Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. (hereinafter referred to as the issuer, Qianhong Pharmaceutical) applies to issue convertible bonds to unspecified objects and list on the main board. In accordance with the relevant provisions of the Company Law, Securities Law, and the Administrative Measures for the Registration of Securities Issuance by Listed Companies (hereinafter referred to as the Refinancing Registration Measures), the issuer submits the issuance application documents. Huatai United Securities Co., Ltd. (hereinafter referred to as Huatai United Securities, the sponsor) acts as the sponsor for this issuance, with Diao Guijun and Zhuang Chen as the designated sponsoring representatives, and hereby issues this sponsorship letter.

The sponsor Huatai United Securities, along with sponsoring representatives Diao Guijun and Zhuang Chen, commits to act in good faith, diligently, and responsibly in accordance with the Company Law, Securities Law, and relevant regulations of the China Securities Regulatory Commission (CSRC) and Shenzhen Stock Exchange, ensuring the authenticity, accuracy, and completeness of the documents provided.

Section 1 Basic Information on the Securities Issuance

1. Sponsor Staff Introduction

   • Sponsoring Representatives: The sponsoring representatives responsible for this recommendation are Diao Guijun and Zhuang Chen. Their sponsorship business experience is as follows:
     • Mr. Diao Guijun, sponsoring representative of Huatai United Securities' investment banking division, has legal qualifications and has led or participated in projects including Wanfu Biology refinancing, Haizhi Science refinancing, WuXi AppTec refinancing, Microelectrophysiology IPO, Aojing Medical IPO, Sanofi Health IPO, Aidi Pharmaceutical IPO, Mindray Medical IPO, and Meizhong Yihe asset restructuring.
     • Mr. Zhuang Chen, director of the investment banking division at Huatai United Securities, sponsoring representative, and non-practicing registered accountant, has participated as a sponsoring representative or core member in IPO projects such as Zhongrui Co., Dongxing Medical, Trina Solar, and Nanjing Julong, as well as Huasheng Group convertible bonds, Jiangsu Leasing convertible bonds, and Jiangsu Suope major asset restructuring projects.
   • Project Coordinator: The project coordinator is Zhang Xiaoqing, whose sponsorship business experience is as follows: Mr. Zhang Xiaoqing: manager of the investment banking division at Huatai United Securities. He has participated in the Innotec IPO project and Wan Dong Medical refinancing projects.
   • Other Project Team Members: Other members involved in this sponsorship work include Ji Lihua, Zhang Xinzhe, Liang Ge, Zhang Wei, and Xue Jie.

2. Issuer Basic Information

   • Company Name: Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
   • Registered Address: No. 518 Yunhe Road, Xinbei District, Changzhou City
   • Establishment Date: April 30, 2003
   • Registered Capital: 1,279.80 million RMB
   • Legal Representative: Wang Ke
   • Contact Information: 0519-86020688
   • Business Scope:
     • Licensed projects: drug production; commissioned drug production; drug wholesale; drug retail; drug import and export (projects requiring approval must be conducted after approval by relevant departments, specific business projects are subject to approval results).
     • General projects: technology import and export; import and export agency; medical packaging materials manufacturing; primary agricultural product acquisition; technology services, technology development, technology consulting, technology exchange, technology transfer, technology promotion; information consulting services (excluding licensed information consulting services); non-residential real estate leasing; housing leasing (except for projects requiring approval, business activities can be conducted independently with a business license).

3. Type of Securities Issuance: Issuance of convertible bonds to unspecified objects.